These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 9324115)

  • 1. Angiotensin I-converting enzyme gene polymorphism and acute response to captopril in essential hypertension.
    Nakano Y; Oshima T; Watanabe M; Matsuura H; Kajiyama G; Kambe M
    Am J Hypertens; 1997 Sep; 10(9 Pt 1):1064-8. PubMed ID: 9324115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of angiotensin I converting enzyme gene polymorphism and angiotensinogen gene polymorphism to blood pressure regulation in essential hypertension.
    Mondorf UF; Russ A; Wiesemann A; Herrero M; Oremek G; Lenz T
    Am J Hypertens; 1998 Feb; 11(2):174-83. PubMed ID: 9524045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the insertion/deletion polymorphism of the angiotensin-converting enzyme gene on response to angiotensin-converting enzyme inhibitors in patients with heart failure.
    O'Toole L; Stewart M; Padfield P; Channer K
    J Cardiovasc Pharmacol; 1998 Dec; 32(6):988-94. PubMed ID: 9869506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A discrepancy between the effects of a single oral dose of captopril on blood pressure, plasma renin activity, and serum angiotensin-converting enzyme levels.
    Lechi A; Covi G; Capuzzo MG; Lechi C; Minuz P; Delva P; Scuro LA
    Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):569-74. PubMed ID: 6317579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between angiotensin-converting enzyme gene polymorphisms and regression of left ventricular hypertrophy in patients treated with angiotensin-converting enzyme inhibitors.
    Kohno M; Yokokawa K; Minami M; Kano H; Yasunari K; Hanehira T; Yoshikawa J
    Am J Med; 1999 May; 106(5):544-9. PubMed ID: 10335726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of
    Dewa A S Handani ; Hermawan A; Ikawati Z
    Pharmacogenomics; 2024; 25(8-9):357-365. PubMed ID: 39069948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of angiotensin-converting enzyme gene polymorphism on proteinuria and arterial hypertension.
    Zivko M; Kusec R; Galesić K
    Coll Antropol; 2013 Sep; 37(3):765-70. PubMed ID: 24308214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study of the relationships between angiotensin- converting enzyme gene, chymase gene polymorphisms, pharmacological treatment with ACE inhibitor and regression of left ventricular hypertrophy in essential hypertension patients treated with benazepril.
    He H; Li LM; Cao WH; Sun NL; Liu MZ; Hu YH
    Ann Hum Biol; 2005; 32(1):30-43. PubMed ID: 15788353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between hypertensive retinopathy and Angiotensin converting enzyme gene polymorphism.
    Baris N; Akdeniz B; Ozerkan F; Onder RM; Akarca U; Guneri S
    Cardiovasc Hematol Disord Drug Targets; 2006 Mar; 6(1):57-61. PubMed ID: 16724936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should the use of short acting angiotensin-converting enzyme inhibitors be abandoned?
    Erman A; Boner G; van Dijk DJ
    J Renin Angiotensin Aldosterone Syst; 2000 Dec; 1(4):365-8. PubMed ID: 11967825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between polymorphism of the angiotensin-converting enzyme gene and the response to angiotensin-converting enzyme inhibition in hypertensive patients.
    Yu H; Zhang Y; Liu G
    Hypertens Res; 2003 Nov; 26(11):881-6. PubMed ID: 14714579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of renin angiotensin system (RAS) candidate gene polymorphisms with response to Ramipril in patients with essential hypertension.
    Gupta S; Chattopadhyaya I; Agrawal BK; Sehajpal PK; Goel RK
    J Postgrad Med; 2015; 61(1):21-6. PubMed ID: 25511213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of insertion/deletion polymorphism of angiotensin-converting enzyme gene among Malay male hypertensive subjects in response to ACE inhibitors.
    Heidari F; Vasudevan R; Mohd Ali SZ; Ismail P; Etemad A; Pishva SR; Othman F; Abu Bakar S
    J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):872-9. PubMed ID: 25002132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme gene I/D polymorphism increases the susceptibility to hypertension and additive diseases: A study on North Indian patients.
    Singh M; Singh AK; Singh S; Pandey P; Chandra S; Gambhir IS
    Clin Exp Hypertens; 2016; 38(3):305-11. PubMed ID: 27030424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum concentration of renin-angiotensin system components in association with ACE I/D polymorphism among hypertensive subjects in response to ACE inhibitor therapy.
    Hristova M; Stanilova S; Miteva L
    Clin Exp Hypertens; 2019; 41(7):662-669. PubMed ID: 30307755
    [No Abstract]   [Full Text] [Related]  

  • 16. Renin-angiotensin system gene polymorphisms influence blood pressure and the response to angiotensin converting enzyme inhibition.
    Hingorani AD; Jia H; Stevens PA; Hopper R; Dickerson JE; Brown MJ
    J Hypertens; 1995 Dec; 13(12 Pt 2):1602-9. PubMed ID: 8903618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Converting enzyme activity and essential hypertension.
    Overlack A; Higuchi M; Kolloch R; Stumpe KO
    Klin Wochenschr; 1983 Apr; 61(7):377-8. PubMed ID: 6306333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DD genotype of the angiotensin I-converting enzyme gene is a risk factor for early onset of essential hypertension in Japanese patients.
    Nakano Y; Oshima T; Hiraga H; Matsuura H; Kajiyama G; Kambe M
    J Lab Clin Med; 1998 Jun; 131(6):502-6. PubMed ID: 9626985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study.
    Parving HH; Jacobsen P; Tarnow L; Rossing P; Lecerf L; Poirier O; Cambien F
    BMJ; 1996 Sep; 313(7057):591-4. PubMed ID: 8806248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-gene interaction between the insertion/deletion polymorphism of the angiotensin-converting enzyme gene and antihypertensive therapy.
    Schelleman H; Klungel OH; van Duijn CM; Witteman JC; Hofman A; de Boer A; Stricker BH
    Ann Pharmacother; 2006 Feb; 40(2):212-8. PubMed ID: 16449550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.